These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 3538870

  • 1. The Norwegian multicenter study.
    Husby G.
    Am J Med; 1986 Nov 28; 81(5B):6-10. PubMed ID: 3538870
    [Abstract] [Full Text] [Related]

  • 2. The Norway study: plasma concentrations, efficacy, and adverse events.
    Rugstad HE.
    Am J Med; 1986 Nov 28; 81(5B):11-4. PubMed ID: 3538865
    [Abstract] [Full Text] [Related]

  • 3. Clinical benefits and comparative safety of piroxicam. Analysis of worldwide clinical trials data.
    Meisel AD.
    Am J Med; 1986 Nov 28; 81(5B):15-21. PubMed ID: 3538866
    [Abstract] [Full Text] [Related]

  • 4. [Fast-dissolving sublingual tablets of piroxicam versus naproxen in the treatment of recurrent acute osteoarthrosis. Multicenter clinical trial].
    Consoli G, Covelli M, Di Matteo L, Marcolongo R, Tirri G, La Montagna G, Pipitone V.
    Minerva Med; 1994 Mar 28; 85(3):89-96. PubMed ID: 8196849
    [Abstract] [Full Text] [Related]

  • 5. Naproxen vs. aspirin in osteoarthritis of the hip and knee.
    Melton JW, Lussier A, Ward JR, Neustadt D, Multz C.
    J Rheumatol; 1978 Mar 28; 5(3):338-46. PubMed ID: 372525
    [Abstract] [Full Text] [Related]

  • 6. [A new non-steroidal anti-inflammatory drug pirprofen (rengasil) in the treatment of rheumatoid arthritis and osteoarthrosis].
    Sigidin IaA, Pokryshkin VI.
    Ter Arkh; 1987 Mar 28; 59(4):73-6. PubMed ID: 2954253
    [Abstract] [Full Text] [Related]

  • 7. Comparison of naproxen and piroxicam in the treatment of rheumatoid arthritis: a double-blind, crossover study.
    Chlud K, Pangerl S.
    Pharmatherapeutica; 1985 Mar 28; 4(2):113-21. PubMed ID: 3903778
    [Abstract] [Full Text] [Related]

  • 8. [Piroxicam and naproxen in arthrosis. A double-blind, comparative multicenter study in general practice].
    Herland OB, Husby G, Giercksky KE, Holme I, Rugstad HE.
    Tidsskr Nor Laegeforen; 1986 Oct 30; 106(30):2487-92. PubMed ID: 3541284
    [No Abstract] [Full Text] [Related]

  • 9. Double-blind comparison of efficacy and gastroduodenal safety of diclofenac/misoprostol, piroxicam, and naproxen in the treatment of osteoarthritis.
    Melo Gomes JA, Roth SH, Zeeh J, Bruyn GA, Woods EM, Geis GS.
    Ann Rheum Dis; 1993 Dec 30; 52(12):881-5. PubMed ID: 8311540
    [Abstract] [Full Text] [Related]

  • 10. Piroxicam and gastrointestinal bleeding.
    Giercksky KE.
    Am J Med; 1986 Nov 28; 81(5B):2-5. PubMed ID: 3491541
    [Abstract] [Full Text] [Related]

  • 11. Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I Study.
    Singh G, Fort JG, Goldstein JL, Levy RA, Hanrahan PS, Bello AE, Andrade-Ortega L, Wallemark C, Agrawal NM, Eisen GM, Stenson WF, Triadafilopoulos G, SUCCESS-I Investigators.
    Am J Med; 2006 Mar 28; 119(3):255-66. PubMed ID: 16490472
    [Abstract] [Full Text] [Related]

  • 12. Piroxicam in juvenile rheumatoid arthritis.
    García-Morteo O, Maldonado-Cocco JA, Cuttica R, Garay SM.
    Eur J Rheumatol Inflamm; 1987 Mar 28; 8(1):49-53. PubMed ID: 2957205
    [Abstract] [Full Text] [Related]

  • 13. A multicenter, randomized, double blind study comparing lornoxicam with diclofenac in osteoarthritis.
    Kidd B, Frenzel W.
    J Rheumatol; 1996 Sep 28; 23(9):1605-11. PubMed ID: 8877932
    [Abstract] [Full Text] [Related]

  • 14. The Effects of cyclooxygenase-2 inhibitors and nonsteroidal anti-inflammatory therapy on 24-hour blood pressure in patients with hypertension, osteoarthritis, and type 2 diabetes mellitus.
    Sowers JR, White WB, Pitt B, Whelton A, Simon LS, Winer N, Kivitz A, van Ingen H, Brabant T, Fort JG, Celecoxib Rofecoxib Efficacy and Safety in Comorbidities Evaluation Trial (CRESCENT) Investigators.
    Arch Intern Med; 2005 Jan 24; 165(2):161-8. PubMed ID: 15668361
    [Abstract] [Full Text] [Related]

  • 15. A double-blind cross-over comparison of piroxicam mane and piroxicam nocte in osteoarthritis.
    Asiedu-Ofei ES, Golding JR.
    Eur J Rheumatol Inflamm; 1981 Jan 24; 4(3):336-41. PubMed ID: 6242955
    [No Abstract] [Full Text] [Related]

  • 16. Multicenter, randomized, double-blind, active-controlled, parallel-group trial of the long-term (6-12 months) safety of acetaminophen in adult patients with osteoarthritis.
    Temple AR, Benson GD, Zinsenheim JR, Schweinle JE.
    Clin Ther; 2006 Feb 24; 28(2):222-35. PubMed ID: 16678643
    [Abstract] [Full Text] [Related]

  • 17. Piroxicam in acute musculoskeletal disorders and sport injuries.
    Heere LP.
    Eur J Rheumatol Inflamm; 1987 Feb 24; 8(1):60-4. PubMed ID: 3305036
    [Abstract] [Full Text] [Related]

  • 18. [Comparison of naproxen and piroxicam in rheumatoid arthritis and Bechterew's syndrome. A double-blind parallel multicenter study].
    Myklebust G.
    Tidsskr Nor Laegeforen; 1986 Jun 20; 106(17-18):1485-7. PubMed ID: 3532419
    [No Abstract] [Full Text] [Related]

  • 19. [Piroxicam versus naproxen in primary dysmenorrhea].
    Saltveit T.
    Tidsskr Nor Laegeforen; 1989 Feb 20; 109(5):576-8. PubMed ID: 2646753
    [Abstract] [Full Text] [Related]

  • 20. Piroxicam and naproxen plasma concentrations in patients with osteoarthritis: relation to age, sex, efficacy and adverse events.
    Rugstad HE, Hundal O, Holme I, Herland OB, Husby G, Giercksky KE.
    Clin Rheumatol; 1986 Sep 20; 5(3):389-98. PubMed ID: 3536263
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.